{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:38:57Z","timestamp":1790959137243,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Scientific and Technological Research Council of T\u00fcrkiye","award":["121S170"],"award-info":[{"award-number":["121S170"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02173-9","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:08:52Z","timestamp":1694700532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Label-free nLC-MS\/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa"],"prefix":"10.1007","volume":"40","author":[{"given":"Sezgin","family":"Zeren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semih","family":"Seker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem Akka\u015f","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Okur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-0701","authenticated-orcid":false,"given":"Azmi","family":"Yerlikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"1","key":"2173_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2173_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2173_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40880-015-0066-y","volume":"35","author":"H Yamagishi","year":"2016","unstructured":"Yamagishi H, Kuroda H, Imai Y, Hiraishi H. Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer. 2016;35:4.","journal-title":"Chin J Cancer"},{"issue":"3","key":"2173_CR4","first-page":"153","volume":"3","author":"M Fleming","year":"2012","unstructured":"Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012;3(3):153\u201373.","journal-title":"J Gastrointest Oncol"},{"issue":"7","key":"2173_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/cancers11071036","volume":"11","author":"A Remo","year":"2019","unstructured":"Remo A, Fassan M, Vanoli A, Bonetti LR, Barresi V, Tatangelo F, Gafa R, Giordano G, Pancione M, Grillo F, et al. Morphology and molecular features of rare colorectal carcinoma histotypes. Cancers. 2019;11(7):1036.","journal-title":"Cancers"},{"issue":"10207","key":"2173_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380.","journal-title":"Lancet"},{"issue":"1","key":"2173_CR7","first-page":"9","volume":"16","author":"HT Nguyen","year":"2018","unstructured":"Nguyen HT, Duong HQ. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy. Oncol Lett. 2018;16(1):9\u201318.","journal-title":"Oncol Lett"},{"issue":"1","key":"2173_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2353\/jmoldx.2008.070082","volume":"10","author":"S Ogino","year":"2008","unstructured":"Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn. 2008;10(1):13\u201327.","journal-title":"J Mol Diagn"},{"issue":"1","key":"2173_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1566524022666211224120614","volume":"23","author":"A Yerlikaya","year":"2023","unstructured":"Yerlikaya A, Zeren S. Molecular pathways, targeted therapies, and proteomic investigations of colorectal cancer. Curr Mol Med. 2023;23(1):2\u201312.","journal-title":"Curr Mol Med"},{"issue":"3","key":"2173_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.21037\/jgo.2019.01.10","volume":"10","author":"L Midthun","year":"2019","unstructured":"Midthun L, Shaheen S, Deisch J, Senthil M, Tsai J, Hsueh CT. Concomitant KRAS and BRAF mutations in colorectal cancer. J Gastrointest Oncol. 2019;10(3):577\u201381.","journal-title":"J Gastrointest Oncol"},{"key":"2173_CR11","doi-asserted-by":"publisher","first-page":"5338956","DOI":"10.1155\/2022\/5338956","volume":"2022","author":"H Yan","year":"2022","unstructured":"Yan H, Jiang F, Yang J. Association of beta-catenin, APC, SMAD3\/4, TP53, and cyclin D1 genes in colorectal cancer: A systematic review and meta-analysis. Genet Res (Camb). 2022;2022:5338956.","journal-title":"Genet Res (Camb)"},{"key":"2173_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13053-017-0065-x","volume":"15","author":"BA Talseth-Palmer","year":"2017","unstructured":"Talseth-Palmer BA. The genetic basis of colonic adenomatous polyposis syndromes. Hered Cancer Clin Pract. 2017;15:5.","journal-title":"Hered Cancer Clin Pract"},{"issue":"10395","key":"2173_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(23)00772-9","volume":"402","author":"A Dasari","year":"2023","unstructured":"Dasari A, Lonardi S, Garcia-Carbonero R, Elez E, Yoshino T, Sobrero A, Yao J, Garcia-Alfonso P, Kocsis J, Cubillo Gracian A, et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): An international, multicentre, randomised, double-blind, phase 3 study. Lancet. 2023;402(10395):41\u201353.","journal-title":"Lancet"},{"issue":"4","key":"2173_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg. 2023;15(4):495\u2013519.","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"2173_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14789450.2020.1713103","volume":"17","author":"DI Cantor","year":"2020","unstructured":"Cantor DI, Cheruku HR, Westacott J, Shin JS, Mohamedali A, Ahn SB. Proteomic investigations into resistance in colorectal cancer. Expert Rev Proteomics. 2020;17(1):49\u201365.","journal-title":"Expert Rev Proteomics"},{"issue":"12","key":"2173_CR16","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3390\/cancers14122928","volume":"14","author":"Q Wang","year":"2022","unstructured":"Wang Q, Shen X, Chen G, Du J. Drug resistance in colorectal cancer: From mechanism to clinic. Cancers. 2022;14(12):2928.","journal-title":"Cancers"},{"issue":"2","key":"2173_CR17","first-page":"1","volume":"13","author":"H\u0130 \u00d6zardal\u0131","year":"2011","unstructured":"\u00d6zardal\u0131 H\u0130, Y\u0131ld\u0131z F, Terzi A, \u00d6zg\u00f6n\u00fcl A, Bitiren M, Y\u0131ld\u0131r\u0131m L, Metineren MH, G\u00fcld\u00fc ME. D2\u201340 immunreactivity in colon adenocarcinomas. Duzce Med J. 2011;13(2):1\u20135.","journal-title":"Duzce Med J"},{"issue":"11","key":"2173_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/cas.12530","volume":"105","author":"K Satoh","year":"2014","unstructured":"Satoh K, Nimura S, Aoki M, Hamasaki M, Koga K, Iwasaki H, Yamashita Y, Kataoka H, Nabeshima K. Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: Possible involvement of c-Met. Cancer Sci. 2014;105(11):1487\u201395.","journal-title":"Cancer Sci"},{"key":"2173_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"issue":"9","key":"2173_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12032-021-01563-1","volume":"38","author":"E Kanbur","year":"2021","unstructured":"Kanbur E, Baykal AT, Yerlikaya A. Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line. Med Oncol. 2021;38(9):112.","journal-title":"Med Oncol"},{"issue":"5","key":"2173_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3906\/biy-1702-44","volume":"41","author":"B \u015eahin","year":"2017","unstructured":"\u015eahin B, Baykal AT. Proteomics analysis of mitochondrial dysfunction triggered by complex specific electron transport chain inhibitors reveals common pathways involving protein misfolding in an SH-SY5Y in vitro cell model. Turk J Biol. 2017;41(5):765\u201384.","journal-title":"Turk J Biol"},{"key":"2173_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jprot.2014.09.010","volume":"113","author":"A Yerlikaya","year":"2015","unstructured":"Yerlikaya A, Okur E, Baykal AT, Acilan C, Boyaci I, Ulukaya E. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line. J Proteomics. 2015;113:315\u201325.","journal-title":"J Proteomics"},{"issue":"10","key":"2173_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240012","volume":"15","author":"E Akgun","year":"2020","unstructured":"Akgun E, Tuzuner MB, Sahin B, Kilercik M, Kulah C, Cakiroglu HN, Serteser M, Unsal I, Baykal AT. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients. PLoS ONE. 2020;15(10): e0240012.","journal-title":"PLoS ONE"},{"key":"2173_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"issue":"D1","key":"2173_CR25","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2173_CR26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"5","key":"2173_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s13277-012-0386-3","volume":"33","author":"A Yerlikaya","year":"2012","unstructured":"Yerlikaya A, Okur E, Ulukaya E. The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib. Tumour Biol. 2012;33(5):1385\u201392.","journal-title":"Tumour Biol"},{"issue":"7","key":"2173_CR28","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1021\/pr900080y","volume":"8","author":"VJ Patel","year":"2009","unstructured":"Patel VJ, Thalassinos K, Slade SE, Connolly JB, Crombie A, Murrell JC, Scrivens JH. A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J Proteome Res. 2009;8(7):3752\u20139.","journal-title":"J Proteome Res"},{"issue":"3","key":"2173_CR29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1200\/JCO.2002.20.3.811","volume":"20","author":"A Jansson","year":"2002","unstructured":"Jansson A, Sun XF. Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J Clin Oncol. 2002;20(3):811\u20136.","journal-title":"J Clin Oncol"},{"key":"2173_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/bs.acr.2015.04.004","volume":"128","author":"X Yu","year":"2015","unstructured":"Yu X, Guo C, Fisher PB, Subjeck JR, Wang XY. Scavenger receptors: Emerging roles in cancer biology and immunology. Adv Cancer Res. 2015;128:309\u201364.","journal-title":"Adv Cancer Res"},{"issue":"21","key":"2173_CR31","doi-asserted-by":"publisher","first-page":"14303","DOI":"10.1074\/jbc.M901026200","volume":"284","author":"B Heinrich","year":"2009","unstructured":"Heinrich B, Zhang Z, Raitskin O, Hiller M, Benderska N, Hartmann AM, Bracco L, Elliott D, Ben-Ari S, Soreq H, et al. Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A\/C)-rich regions in pre-mRNA. J Biol Chem. 2009;284(21):14303\u201315.","journal-title":"J Biol Chem"},{"issue":"4","key":"2173_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.celrep.2012.02.005","volume":"1","author":"S Matsunaga","year":"2012","unstructured":"Matsunaga S, Takata H, Morimoto A, Hayashihara K, Higashi T, Akatsuchi K, Mizusawa E, Yamakawa M, Ashida M, Matsunaga TM, et al. RBMX: A regulator for maintenance and centromeric protection of sister chromatid cohesion. Cell Rep. 2012;1(4):299\u2013308.","journal-title":"Cell Rep"},{"issue":"19","key":"2173_CR33","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.3390\/cancers13194788","volume":"13","author":"FL Schumann","year":"2021","unstructured":"Schumann FL, Bauer M, Gross E, Terziev D, Wienke A, Wickenhauser C, Binder M, Weber T. RBMX protein expression in T-cell lymphomas predicts chemotherapy response and prognosis. Cancers. 2021;13(19):4788.","journal-title":"Cancers"},{"issue":"11","key":"2173_CR34","first-page":"3644","volume":"10","author":"Y Song","year":"2020","unstructured":"Song Y, He S, Ma X, Zhang M, Zhuang J, Wang G, Ye Y, Xia W. RBMX contributes to hepatocellular carcinoma progression and sorafenib resistance by specifically binding and stabilizing BLACAT1. Am J Cancer Res. 2020;10(11):3644\u201365.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2173_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s42003-020-01590-0","volume":"4","author":"X Hu","year":"2021","unstructured":"Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Gong Y, Song J, Krishnamurthy S, Ueno NT, Tripathy D, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4(1):72.","journal-title":"Commun Biol"},{"issue":"9","key":"2173_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1369\/0022155415590830","volume":"63","author":"MC Nyman","year":"2015","unstructured":"Nyman MC, Sainio AO, Pennanen MM, Lund RJ, Vuorikoski S, Sundstrom JT, Jarvelainen HT. Decorin in human colon cancer: Localization in vivo and effect on cancer cell behavior in vitro. J Histochem Cytochem. 2015;63(9):710\u201320.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"2173_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1172\/JCI119507","volume":"100","author":"M Santra","year":"1997","unstructured":"Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest. 1997;100(1):149\u201357.","journal-title":"J Clin Invest"},{"issue":"3","key":"2173_CR38","doi-asserted-by":"publisher","first-page":"C554","DOI":"10.1152\/ajpcell.00016.2022","volume":"322","author":"C Xie","year":"2022","unstructured":"Xie C, Mondal DK, Ulas M, Neill T, Iozzo RV. Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways. Am J Physiol Cell Physiol. 2022;322(3):C554\u201366.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"2173_CR39","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1074\/jbc.274.8.4489","volume":"274","author":"RV Iozzo","year":"1999","unstructured":"Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem. 1999;274(8):4489\u201392.","journal-title":"J Biol Chem"},{"issue":"37","key":"2173_CR40","doi-asserted-by":"publisher","first-page":"32468","DOI":"10.1074\/jbc.M503833200","volume":"280","author":"JX Zhu","year":"2005","unstructured":"Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem. 2005;280(37):32468\u201379.","journal-title":"J Biol Chem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02173-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T03:47:21Z","timestamp":1695959241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02173-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02173-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Kutahya Health Sciences University under the number 2021\/06\u201317.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"298"}}